Access cutting-edge myeloid malignancy treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Rochester location
Preparing your pre-screening questions…
Access myeloid malignancy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myeloid malignancy treatment provided free
Check if you qualify for this myeloid malignancy clinical trial in Rochester, NY
No-Cost Study Care
Local to Rochester
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.
Sponsor: University of Rochester
Yes, this clinical trial (NCT05875805) has an active research site in Rochester, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for myeloid malignancy treatment options in Rochester, NY, this clinical trial (NCT05875805) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myeloid malignancy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all myeloid malignancy clinical trials near you to find additional studies recruiting in your area.
See all osteogenesis imperfecta clinical trials recruiting in Rochester — not just this study.
Browse Osteogenesis Imperfecta Trials in Rochester →